State Specialty Directory
Ophthalmology in OH
Federal CMS data for 296 ophthalmology providers across OH. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.
296
Providers
Median industry payments
$1,872
296
Ophthalmology Providers
in OH
$1,872
Median Industry Payments
per provider (2018–2024)
1,604
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only
Medicare fee-for-service patients (typically 65+). This does not represent total practice volume.
Industry payments span multiple years and payment types — they are legal and do not indicate wrongdoing.
Ophthalmology includes multiple subspecialties with different practice patterns.
Learn more →
Showing top 50 of 296 providers, ranked by Medicare service volume. Search by city to narrow results.
Ophthalmology Providers — OH
NPPES · Open Payments · Medicare| Provider | City | Medicare Volume | Beneficiaries* | Top Procedure | Industry Payments | Payment Type | Coverage |
|---|---|---|---|---|---|---|---|
| RAO, LLEWELYN MD | Beachwood | 46,003 | 5,608 | Eye injection (Vabysmo/faricimab) | $58,350 (2018-2024) | Consulting (40%) | Very High |
| CHORICH, LOUIS MD | Dublin | 45,511 | 2,938 | Eye injection (Vabysmo/faricimab) | $40,703 (2018-2024) | Ownership/Investment (89%) | Very High |
| CONEY, JOSEPH M.D. | Beachwood | 44,379 | 3,418 | Eye injection (Vabysmo/faricimab) | $844,265 (2018-2024) | Consulting (58%) | Very High |
| SISK, ROBERT MD | Cincinnati | 40,254 | 2,002 | Eye injection (Vabysmo/faricimab) | $46,612 (2018-2024) | Consulting (83%) | Very High |
| PENDERGAST, SCOTT M.D. | Beachwood | 39,861 | 5,228 | Eye injection (Vabysmo/faricimab) | $65,693 (2018-2024) | Acquisitions (65%) | Very High |
| OSHER, JAMES M.D. | Blue Ash | 38,488 | 3,818 | Eye injection (Vabysmo/faricimab) | $10,626 (2018-2024) | Consulting (53%) | Very High |
| LINDSELL, LUCAS M.D., O.D. | Blue Ash | 38,277 | 2,668 | Eye injection (Vabysmo/faricimab) | $88,540 (2018-2024) | Consulting (78%) | Very High |
| CHRISTOFORIDIS, JOHN M.D. | Columbus | 33,836 | 4,257 | Eye injection (Vabysmo/faricimab) | $8,685 (2018-2024) | Food & Beverage (100%) | Very High |
| BUERK, BRUCE MD | Dayton | 31,895 | 3,915 | Eye injection (Vabysmo/faricimab) | $506 (2018-2023) | Food & Beverage (100%) | Very High |
| NOVAK, MICHAEL MD | Beachwood | 29,660 | 4,021 | Eye injection (Vabysmo/faricimab) | $69,817 (2018-2024) | Acquisitions (61%) | Very High |
| PHAM, HANG M.D. | Beachwood | 26,684 | 3,545 | Eye injection (Vabysmo/faricimab) | $9,357 (2018-2024) | Food & Beverage (75%) | Very High |
| WENZ, ROBERT M.D. | Canton | 25,374 | 2,353 | Eye injection (Vabysmo/faricimab) | $2,014 (2018-2024) | Food & Beverage (99%) | Very High |
| NOTHNAGEL, ARNOLD DO | Canton | 24,184 | 2,550 | Eye injection (Vabysmo/faricimab) | $4,018 (2018-2024) | Food & Beverage (100%) | Very High |
| FOSTER, ROBERT M.D. | Cincinnati | 21,763 | 2,863 | Eye injection (Vabysmo/faricimab) | $1,536 (2018-2024) | Food & Beverage (100%) | Very High |
| KIM, JOHNSTONE MD | Dublin | 21,648 | 2,725 | Eye injection (Vabysmo/faricimab) | $10,210 (2018-2024) | Ownership/Investment (86%) | Very High |
| MILLER, DANIEL MD | Cincinnati | 20,842 | 2,446 | Eye injection (Vabysmo/faricimab) | $83,210 (2018-2024) | Consulting (73%) | Very High |
| RIEMANN, CHRISTOPHER M.D. | Cincinnati | 20,022 | 2,573 | Eye injection (Vabysmo/faricimab) | $522,097 (2018-2024) | Consulting (77%) | Very High |
| CONTI, STEPHEN M.D. | Canton | 18,212 | 3,023 | Eye injection (Vabysmo/faricimab) | $1,274 (2018-2023) | Food & Beverage (100%) | Very High |
| BORKOWSKI, LISA MD | Columbus | 17,808 | 2,323 | Eye injection (Vabysmo/faricimab) | $24,251 (2018-2024) | Ownership/Investment (81%) | Very High |
| PATEL, CHIRAG MD | Columbus | 16,967 | 2,599 | Eye injection (Vabysmo/faricimab) | $2,134 (2018-2024) | Food & Beverage (100%) | Very High |
| CHAUDHRY, HAROON M.D. | Cincinnati | 16,737 | 4,284 | Eye injection (Vabysmo/faricimab) | $5,313 (2018-2024) | Food & Beverage (100%) | Very High |
| PATEL, SUGAT MD | Dublin | 16,683 | 2,744 | Eye injection (Vabysmo/faricimab) | $31,329 (2018-2024) | Ownership/Investment (70%) | Very High |
| HUNT, CHRISTIANE DO | Columbus | 16,579 | 2,303 | Eye injection (Vabysmo/faricimab) | $3,678 (2018-2024) | Food & Beverage (100%) | Very High |
| PFAHLER, SCOTT D.O. | Dayton | 16,122 | 3,008 | Eye injection (Vabysmo/faricimab) | $5,884 (2018-2024) | Food & Beverage (64%) | Very High |
| HUTCHINS, ROBERT MD | Cincinnati | 15,220 | 2,272 | Eye injection (Vabysmo/faricimab) | $4,933 (2018-2024) | Food & Beverage (100%) | Very High |
| MODI, YASHA M.D. | Cleveland | 15,062 | 3,556 | Eye injection (Vabysmo/faricimab) | $225,018 (2018-2024) | Consulting (83%) | Very High |
| KLISOVIC, DINO M.D. | Dublin | 14,715 | 2,055 | Eye injection (Vabysmo/faricimab) | $19,951 (2018-2024) | Ownership/Investment (88%) | Very High |
| PAJKA, JOHN MD | Lima | 12,983 | 1,777 | Cataract surgery with lens implant | $1,058 (2018-2024) | Food & Beverage (85%) | Very High |
| SCHARTMAN, JEROME M.D. | Beachwood | 12,656 | 3,760 | Aflibercept eye injection (Eylea) | $29,541 (2018-2024) | Acquisitions (58%) | Very High |
| GODUNI, LEDIANA MD | Beachwood | 11,961 | 2,467 | Eye injection (Vabysmo/faricimab) | $8,140 (2019-2024) | Food & Beverage (49%) | Very High |
| BUZZACCO, DOMINIC M.D. | Dublin | 11,621 | 2,594 | Eye injection (Vabysmo/faricimab) | $10,954 (2018-2024) | Ownership/Investment (80%) | Very High |
| BERNSTEIN, JONATHAN M.D. | Toledo | 10,133 | 2,673 | Eye injection (Vabysmo/faricimab) | $7,755 (2018-2024) | Gift (83%) | Very High |
| WILKER, SHAWN MD | Beachwood | 9,084 | 1,307 | Eye injection (Vabysmo/faricimab) | $3,907 (2018-2024) | Food & Beverage (68%) | Very High |
| SMITH, SARAH M.D. | Youngstown | 8,861 | 1,638 | Eye injection (Vabysmo/faricimab) | $1,779 (2018-2024) | Food & Beverage (100%) | Very High |
| JOHNSON, CHRISTOPHER MD | Sidney | 8,841 | 3,209 | Cataract surgery with lens implant | $3,800 (2018-2024) | Food & Beverage (94%) | Very High |
| DAUN, MICHAEL M.D. | Cincinnati | 8,623 | 1,499 | Eye injection (Vabysmo/faricimab) | $2,646 (2018-2024) | Food & Beverage (100%) | Very High |
| WELLS, MICHAEL M.D. | Columbus | 8,134 | 693 | Eye injection (Vabysmo/faricimab) | $58 (2018-2023) | Food & Beverage (100%) | Very High |
| ORR, STEPHEN MD | Findlay | 8,067 | 4,409 | Cataract surgery with lens implant | $7,011 (2018-2024) | Food & Beverage (66%) | Very High |
| STEPHENS, JEFFERY M.D. | Toledo | 7,567 | 2,161 | Eye injection (Vabysmo/faricimab) | $2,142 (2018-2024) | Food & Beverage (100%) | Very High |
| SHAH, NIRAJ M.D. | Toledo | 7,567 | 2,696 | Retinal imaging (OCT scan) | $9,510 (2018-2024) | Consulting (69%) | Very High |
| KATZ, STEVEN MD | Columbus | 6,849 | 1,190 | Botox injection, per unit | $202,140 (2018-2024) | Consulting (55%) | Very High |
| ABDULAAL, MARWAN M.D. | Fairfield | 6,663 | 1,522 | Eye injection (Vabysmo/faricimab) | $2,502 (2018-2024) | Food & Beverage (100%) | Very High |
| ROSENTHAL, JOHN M.D. | Maumee | 6,657 | 2,636 | Retinal imaging (OCT scan) | $80 (2018-2023) | Food & Beverage (100%) | Very High |
| BROWN, RONALD MD | Toledo | 6,403 | 1,977 | Cataract surgery with lens implant | $606 (2018-2024) | Food & Beverage (94%) | Very High |
| LOTHES, ERIC M.D. | Powell | 5,844 | 1,822 | Cataract surgery with lens implant | $45 (2021-2022) | Food & Beverage (100%) | Very High |
| KOSMIDIS, ALEXANDER MD | Fairview Park | 5,811 | 4,315 | Optic nerve imaging (OCT scan) | $4,255 (2018-2024) | Food & Beverage (60%) | Very High |
| SASTRY, ANANTH M.D. | Cleveland | 5,735 | 1,626 | Eye injection (Vabysmo/faricimab) | $28,709 (2018-2024) | Consulting (75%) | Very High |
| KODE, RAMESH MD | Cincinnati | 5,532 | 1,999 | Cataract surgery with lens implant | $2,117 (2018-2024) | Food & Beverage (100%) | Very High |
| MILLER, AMY MD | Dayton | 5,379 | 3,975 | Office visit, established patient (20-29 min) | $416,840 (2018-2024) | Consulting (98%) | Very High |
| AL-SHWEIKI, SAMEER M.D. | Toledo | 5,009 | 900 | Eye injection (Vabysmo/faricimab) | $6,090 (2021-2024) | Food & Beverage (71%) | Very High |
Note: Ophthalmology encompasses multiple subspecialties with different practice patterns.
Differences in payment amounts and procedure volumes may reflect subspecialty focus
rather than practice quality. Consider viewing individual profiles for full context.